---
title: "Context-dependent variability of NOTCH3 p.Arg1231Cys: from asymptomatic carriers to CADASIL and li"
id: "medrxiv-9-from-asymptomatic-carriers-to-cadasil-context-dependent-phenotypic-variability"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-9-from-asymptomatic-carriers-to-cadasil-context-dependent-phenotypic-variability"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.03.26364647v1?rss=1"
published_at: "2026-10-06T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Context-dependent variability of NOTCH3 p.Arg1231Cys: from asymptomatic carriers to CADASIL and li
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-9-from-asymptomatic-carriers-to-cadasil-context-dependent-phenotypic-variability
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.03.26364647v1?rss=1)
- **Published At:** 2026-10-06T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study examined phenotypic variability associated with the pathogenic **NOTCH3 p.Arg1231Cys** variant across three European recruitment settings: a multigenerational founder population in Cilento, Italy (CILCAD), a UK Biobank population-based cohort (UKB), and a clinically referred cohort from Lariboisiere Hospital, Paris (LRB). - Investigators compared clinical features, MRI markers, and cardiovascular risk factors between carriers in the three cohorts and, within the Cilento population, between carriers and local non-carriers from the same community. - Results showed marked **context-dependent phenotypic variability** associated with the identical NOTCH3 p.Arg1231Cys mutation: expression ranged from asymptomatic carriage to clinically manifest CADASIL in different settings. - Haplotype analysis in the CILCAD founder population identified that the haplotype carrying the NOTCH3 mutation was also associated with **decreased LDL cholesterol** levels in that population. - Unexpectedly, these unusually low **LDL** levels in the CILCAD sample correlated with a higher likelihood of stroke among carriers in that population. - The findings suggest factors beyond mutation position within the NOTCH3 receptor — including genetic background and population context — can substantially shape CADASIL expression for the same variant. - The study used MRI and cardiovascular risk factor profiling to characterize disease expression across cohorts; details on specific MRI metrics and statistical values were not reported in the abstract. - Data sources include UK Biobank (available under UKB access rules) and cohort data from Cilento and the French referral centre; individual-level Cilento and French data are not publicly available due to privacy and ethical restrictions. - This work is a preprint that has not been peer reviewed; authors declared no competing interests and reported relevant IRB/ethics approvals for the cohorts involved.
## Clinical Analysis & Structured Key Points
FROM ASYMPTOMATIC CARRIERS TO CADASIL: CONTEXT-DEPENDENT PHENOTYPIC VARIABILITY OF THE NOTCH3 P.ARG1231CYS VARIANT ACROSS THREE EUROPEAN COHORTS AND POTENTIAL IMPLICATIONS OF LDL CHOLESTEROL | medRxiv Skip to main content FROM ASYMPTOMATIC CARRIERS TO CADASIL: CONTEXT-DEPENDENT PHENOTYPIC VARIABILITY OF THE NOTCH3 P.ARG1231CYS VARIANT ACROSS THREE EUROPEAN COHORTS AND POTENTIAL IMPLICATIONS OF LDL CHOLESTEROL Teresa Nutile , Daniela Ruggiero , Matthieu Pluntz , Jessica Lebenberg , Louis Lambert , Lorenzo Cipriano , Andrea Di Pietro , Veronica Sandroni , Pasqualina Cennamo , Dominique Herve , Stephanie Guey , Maria Domenica Calabrese , Serena Lucibello , Anthony F Herzig , Luigi Trojano , Vincenzo Pizza , Elisabeth Tournier-Lasserve , Herve Perdry , Hugues Chabriat , Anne-Louise Leutenegger , Marina Ciullo doi: https://doi.org/10.64898/2026.10.03.26364647 Teresa Nutile 1 Institute of Genetics and Biophysics A. Buzzati-Traverso, CNR, Naples, Italy; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Daniela Ruggiero 1 Institute of Genetics and Biophysics A. Buzzati-Traverso, CNR, Naples, Italy; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Matthieu Pluntz 2 Universite Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jessica Lebenberg 3 Sorbonne Universite, Inserm, CNRS, AP-HP, Institut du Cerveau, ICM, 75013, Paris, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Louis Lambert 3 Sorbonne Universite, Inserm, CNRS, AP-HP, Institut du Cerveau, ICM, 75013, Paris, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Lorenzo Cipriano 4 Dept. of molecular medicine and Medical Biotechnology, University Federico II, Naples, Italy; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Andrea Di Pietro 5 Dept. of Neurology and Stroke Unit, AORN SantAnna e San Sebastiano, Caserta, Italy; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Veronica Sandroni 6 Univ Paris Est Creteil, INSERM, IMRB, AP-HP, Hopitaux Universitaires H. Mondor, DMU IMPACT, Fondation FondaMental, 94010, Creteil, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Pasqualina Cennamo 1 Institute of Genetics and Biophysics A. Buzzati-Traverso, CNR, Naples, Italy; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Dominique Herve 7 APHP, Translational Neurovascular Centre and CERVCO, Hopital Lariboisiere,75010, Paris, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Stephanie Guey 7 APHP, Translational Neurovascular Centre and CERVCO, Hopital Lariboisiere,75010, Paris, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Maria Domenica Calabrese 8 Dept. of Emergency and Time Dependent Networks, Neurology Unit, S.Luca Hospital, Vallo Della Lucania, Italy; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Serena Lucibello 8 Dept. of Emergency and Time Dependent Networks, Neurology Unit, S.Luca Hospital, Vallo Della Lucania, Italy; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anthony F Herzig 9 Universite de Bretagne Occidentale, Inserm, EFS, GGB, UMR 1078, 29238, Brest, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Luigi Trojano 10 Dep. of Psychology, University of Campania Luigi Vanvitelli, Caserta, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site Vincenzo Pizza 7 APHP, Translational Neurovascular Centre and CERVCO, Hopital Lariboisiere,75010, Paris, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Elisabeth Tournier-Lasserve 3 Sorbonne Universite, Inserm, CNRS, AP-HP, Institut du Cerveau, ICM, 75013, Paris, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Herve Perdry 2 Universite Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hugues Chabriat 3 Sorbonne Universite, Inserm, CNRS, AP-HP, Institut du Cerveau, ICM, 75013, Paris, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anne-Louise Leutenegger 2 Universite Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: anne-louise.leutenegger{at}inserm.fr Marina Ciullo 1 Institute of Genetics and Biophysics A. Buzzati-Traverso, CNR, Naples, Italy; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background: CADASIL caused by cysteine-altering NOTCH3 variants, the most frequent hereditary cerebral small vessel disease worldwide, is characterized by marked phenotypic variability. Mutation location within the EGFr domains of the NOTCH3 receptor has emerged as a key determinant of this variability. We investigated phenotypic variability and potential modifiers of CADASIL expression by comparing individuals harbouring the same pathogenic NOTCH3 variant across distinct recruitment settings in three European countries. Methods: We compared clinical features, MRI markers, and cardiovascular risk factors among individuals harbouring the p.Arg1231Cys NOTCH3 mutation across three distinct recruitment settings: a multigenerational founder population from Cilento, Italy (CILCAD), a population-based cohort from the UK Biobank (UKB), and a clinically referred cohort from a national referral centre in Lariboisiere Hospital, Paris, France (LRB). In addition, CILCAD carriers were compared with NON-Carriers from the same population. The NOTCH3 locus was finally analysed to define the shared haplotype in CILCAD and explore potential genetic contributions to phenotypic variability. Findings: By comparing populations from three European countries, this study showed marked context-dependent phenotypic variability associated with the sole pathogenic p.Arg1231Cys NOTCH3 variant. In CILCAD, a multigenerational founder population, the haplotype carrying the NOTCH3 mutation also predisposes to decreased LDL levels, resulting in an unusually low LDL cholesterol profile in this sample. Strikingly, these very low LDL levels were associated with a higher likelihood of stroke. Interpretation: In European carriers of NOTCH3 p.Arg1231Cys, factors beyond mutation location, including genetic background, may substantially shape disease expression, while exceptionally low LDL levels could paradoxically be associated with greater disease severity. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: - Ethics committee/IRB of University of Naples Federico II gave ethical approval for this work under reference number 191/19 - Ethics committee/IRB of Institut national de la sante et de la recherche medicale (INSERM CEEI-IRB 00003888) gave approval for this work under the reference 17/388 I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The data used in this study originate from three sources. UK Biobank data are available to bona fide researchers through the UK Biobank data access procedures. Data from the Cilento population study and individual-level patient data collected at the French National Referral Center for Rare Cerebrovascular Diseases (CERVCO, AP-HP) are not publicly available due to privacy, ethical and legal restrictions. Access to these data may be considered upon reasonable request, subject to applicable regulations and approval by the relevant institutions. Funder Information Declared Alzheimer's Association, https://ror.org/0375f4d26 , AARG-NTF-20-683992 Agence Nationale de la Recherche , ANR-20-CE17-0031 Consiglio Nazionale delle Ricerche , FOE-2021- DBA.AD005.225 , FOE 2022 - DSB.AD006.371 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted October 06, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following FROM ASYMPTOMATIC CARRIERS TO CADASIL: CONTEXT-DEPENDENT PHENOTYPIC VARIABILITY OF THE NOTCH3 P.ARG1231CYS VARIANT ACROSS THREE EUROPEAN COHORTS AND POTENTIAL IMPLICATIONS OF LDL CHOLESTEROL Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share FROM ASYMPTOMATIC CARRIERS TO CADASIL: CONTEXT-DEPENDENT PHENOTYPIC VARIABILITY OF THE NOTCH3 P.ARG1231CYS VARIANT ACROSS THREE EUROPEAN COHORTS AND POTENTIAL IMPLICATIONS OF LDL CHOLESTEROL Teresa Nutile , Daniela Ruggiero , Matthieu Pluntz , Jessica Lebenberg , Louis Lambert , Lorenzo Cipriano , Andrea Di Pietro , Veronica Sandroni , Pasqualina Cennamo , Dominique Herve , Stephanie Guey , Maria Domenica Calabrese , Serena Lucibello , Anthony F Herzig , Luigi Trojano , Vincenzo Pizza , Elisabeth Tournier-Lasserve , Herve Perdry , Hugues Chabriat , Anne-Louise Leutenegger , Marina Ciullo medRxiv 2026.10.03.26364647; doi: https://doi.org/10.64898/2026.10.03.26364647 Share This Article: Copy Citation Tools FROM ASYMPTOMATIC CARRIERS TO CADASIL: CONTEXT-DEPENDENT PHENOTYPIC VARIABILITY OF THE NOTCH3 P.ARG1231CYS VARIANT ACROSS THREE EUROPEAN COHORTS AND POTENTIAL IMPLICATIONS OF LDL CHOLESTEROL Teresa Nutile , Daniela Ruggiero , Matthieu Pluntz , Jessica Lebenberg , Louis Lambert , Lorenzo Cipriano , Andrea Di Pietro , Veronica Sandroni , Pasqualina Cennamo , Dominique Herve , Stephanie Guey , Maria Domenica Calabrese , Serena Lucibello , Anthony F Herzig , Luigi Trojano , Vincenzo Pizza , Elisabeth Tournier-Lasserve , Herve Perdry , Hugues Chabriat , Anne-Louise Leutenegger , Marina Ciullo medRxiv 2026.10.03.26364647; doi: https://doi.org/10.64898/2026.10.03.26364647 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Neurology Subject Areas All Articles Addiction Medicine (626) Allergy and Immunology (914) Anesthesia (341) Cardiovascular Medicine (4887) Dentistry and Oral Medicine (486) Dermatology (421) Emergency Medicine (660) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1647) Epidemiology (16070) Forensic Medicine (34) Gastroenterology (1218) Genetic and Genomic Medicine (7129) Geriatric Medicine (737) Health Economics (1073) Health Informatics (5130) Health Policy (1447) Health Systems and Quality Improvement (1794) Hematology (591) HIV/AIDS (1356) Infectious Diseases (except HIV/AIDS) (16363) Intensive Care and Critical Care Medicine (1185) Medical Education (678) Medical Ethics (156) Nephrology (729) Neurology (7391) Nursing (371) Nutrition (1102) Obstetrics and Gynecology (1263) Occupational and Environmental Health (1010) Oncology (3661) Ophthalmology (1067) Orthopedics (399) Otolaryngology (460) Pain Medicine (484) Palliative Medicine (142) Pathology (711) Pediatrics (1823) Pharmacology and Therapeutics (741) Primary Care Research (777) Psychiatry and Clinical Psychology (5993) Public and Global Health (9841) Radiology and Imaging (2467) Rehabilitation Medicine and Physical Therapy (1480) Respiratory Medicine (1257) Rheumatology (653) Sexual and Reproductive Health (786) Sports Medicine (588) Surgery (786) Toxicology (107) Transplantation (310) Urology (299)
## Related Clinical Research

- [Plasma p‑tau217, p‑tau181, GFAP and NfL Predict Diagnosis and Long‑Term Progression in a 3,645‑Pat](https://medichelpline.com/clinical-feed/medrxiv-20-plasma-biomarkers-and-incident-clinical-stage-progression-in-the-specialized.md)
- [Ultra-processed foods linked to MRI signs of vascular brain injury in middle-aged adults](https://medichelpline.com/clinical-feed/medical-news-today-0-ultra-processed-foods-may-be-harming-brain-health-in-otherwise-healthy-adults.md)
- [Global dementia incidence projected to reach 24.7 million new cases annually by 2050](https://medichelpline.com/clinical-feed/medical-news-today-0-dementia-cases-to-double-by-2050-why-women-some-countries-may-be-at-higher-risk.md)
- [Explainable multimodal speech framework for detecting depression-related signals in Alzheimer's di](https://medichelpline.com/clinical-feed/medrxiv-0-an-explainable-multimodal-framework-for-exploring-depression-associated-speech.md)
- [Pre-diagnostic 1-year prevalence of polypharmacy and PIMcog in Norwegian outpatients with MCI or d](https://medichelpline.com/clinical-feed/plos-one-14-one-year-pre-diagnostic-prevalence-and-associated-factors-of-polypharmacy-and.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.